What to know ahead of Moderna-Merck cancer vaccine data reveal
Key Points:
- Adam’s Biotech Scorecard is a weekly newsletter offering exclusive analysis on the biotech industry, available via email subscription.
- The author has arrived in Madrid for the European Society for Medical Oncology (ESMO) Congress and plans to provide updates through the "ESMO in 30" newsletter.
- STAT’s Europe correspondent and the author will cover key developments from the ESMO Congress, offering insights beyond the event itself.
- Anticipation is building for the upcoming data reveal on the Moderna-Merck cancer vaccine, expected to provide important information soon.